|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Vir Biotechnology, Inc. (VIR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
127,390,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
10,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$246,341 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
81,714 |
167,399 |
462,055 |
6,000,552 |
| Total Sell Value |
$777,020 |
$1,671,921 |
$9,342,894 |
$153,832,815 |
| Total People Sold |
3 |
5 |
7 |
11 |
| Total Sell Transactions |
3 |
10 |
18 |
121 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scangos George A |
President and CEO |
• • – |
2023-02-24 |
4 |
AS |
$22.74 |
$352,682 |
D/D |
(15,119) |
168,489 |
|
- |
|
| Horn Howard |
CFO |
• – – |
2023-02-23 |
4 |
S |
$25.97 |
$58,387 |
D/D |
(2,248) |
230,712 |
|
- |
|
| Hanly Ann M. |
Chief Technology Officer |
• – – |
2023-02-23 |
4 |
S |
$25.97 |
$59,790 |
D/D |
(2,302) |
117,203 |
|
- |
|
| Rice Steven J. |
Chief Administrative Officer |
• – – |
2023-02-23 |
4 |
S |
$25.97 |
$46,622 |
D/D |
(1,795) |
108,414 |
|
- |
|
| Scangos George A |
President and CEO |
• • – |
2023-02-23 |
4 |
AS |
$25.97 |
$328,065 |
D/D |
(12,631) |
183,608 |
|
- |
|
| Pang Phillip |
Chief Medical Officer |
• – – |
2023-02-23 |
4 |
S |
$25.97 |
$74,750 |
D/D |
(2,878) |
198,320 |
|
- |
|
| Hanly Ann M. |
Chief Technology Officer |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
119,505 |
|
- |
|
| Rice Steven J. |
Chief Administrative Officer |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
73,000 |
110,209 |
|
- |
|
| Friedl-Naderer Johanna |
EVP & Chief Operating Officer |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
150,000 |
|
- |
|
| Pang Phillip |
Chief Medical Officer |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
201,198 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-21 |
4 |
AS |
$26.95 |
$2,117,336 |
I/I |
(74,477) |
18,319,938 |
|
- |
|
| Scangos George A |
President and CEO |
• • – |
2023-02-21 |
4 |
AS |
$28.02 |
$505,318 |
D/D |
(17,856) |
196,239 |
|
- |
|
| Pang Phillip |
Chief Medical Officer |
• – – |
2023-02-17 |
4 |
S |
$25.29 |
$70,857 |
D/D |
(2,802) |
141,198 |
|
- |
|
| Rice Steven J. |
Chief Administrative Officer |
• – – |
2023-02-17 |
4 |
S |
$25.29 |
$50,096 |
D/D |
(1,981) |
37,209 |
|
- |
|
| Scangos George A |
President and CEO |
• • – |
2023-02-17 |
4 |
AS |
$25.29 |
$250,199 |
D/D |
(9,894) |
214,095 |
|
- |
|
| Horn Howard |
CFO |
• – – |
2023-02-17 |
4 |
S |
$25.29 |
$61,298 |
D/D |
(2,424) |
232,960 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-15 |
4 |
AS |
$26.75 |
$1,042,384 |
I/I |
(38,964) |
18,394,415 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-14 |
4 |
AS |
$26.81 |
$1,043,108 |
I/I |
(38,907) |
18,433,379 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-13 |
4 |
AS |
$25.77 |
$2,056,585 |
I/I |
(79,050) |
18,472,286 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-10 |
4 |
AS |
$25.94 |
$2,540,300 |
I/I |
(97,221) |
18,551,336 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-09 |
4 |
AS |
$25.99 |
$3,615,729 |
I/I |
(137,050) |
18,648,557 |
|
- |
|
| Sato Vicki L |
Director |
– • – |
2023-02-08 |
4 |
AS |
$28.35 |
$508,343 |
D/D |
(17,915) |
1,345,259 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-08 |
4 |
AS |
$27.32 |
$2,284,153 |
I/I |
(81,914) |
18,785,607 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-07 |
4 |
AS |
$28.92 |
$1,862,396 |
I/I |
(63,508) |
18,867,521 |
|
- |
|
| Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2023-02-06 |
4 |
AS |
$29.84 |
$1,353,849 |
I/I |
(45,249) |
18,931,029 |
|
- |
|
585 Records found
|
|
Page 4 of 24 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
